---
title: "Amphetamine - Attention Deficit Disorder With Hyperactivity"
sidebar: mydoc_sidebar
permalink: db00182-mesh-d001289-1.html
toc: false 
---


Path ID: `DB00182_MESH_D001289_1`
{% include image.html url="images/db00182-mesh-d001289-1.png" file="db00182-mesh-d001289-1.png" alt="db00182-mesh-d001289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000661">MESH:D000661 </a> | Amphetamine | Drug |
| <a href="https://identifiers.org/UniProt:Q05940">UniProt:Q05940 </a> | Synaptic vesicular amine transporter | Protein |
| <a href="https://identifiers.org/GO:0098810">GO:0098810 </a> | neurotransmitter reuptake | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:Q96RJ0">UniProt:Q96RJ0 </a> | Trace amine-associated receptor 1 | Protein |
| <a href="https://identifiers.org/MESH:D009638">MESH:D009638 </a> | Norepinephrine | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D004298">MESH:D004298 </a> | Dopamine | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D009638">MESH:D009638 </a> | Norepinephrine | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D012701">MESH:D012701 </a> | Serotonin | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D001289">MESH:D001289 </a> | Attention Deficit Disorder with Hyperactivity | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Amphetamine | DECREASES ACTIVITY OF | Synaptic Vesicular Amine Transporter |
| Amphetamine | NEGATIVELY REGULATES | Neurotransmitter Reuptake |
| Amphetamine | INCREASES ACTIVITY OF | Trace Amine-Associated Receptor 1 |
| Synaptic Vesicular Amine Transporter | POSITIVELY REGULATES | Neurotransmitter Reuptake |
| Trace Amine-Associated Receptor 1 | NEGATIVELY REGULATES | Neurotransmitter Reuptake |
| Neurotransmitter Reuptake | INCREASES ABUNDANCE OF | Dopamine |
| Neurotransmitter Reuptake | INCREASES ABUNDANCE OF | Norepinephrine |
| Neurotransmitter Reuptake | INCREASES ABUNDANCE OF | Serotonin |
| Dopamine | CONTRIBUTES TO | Attention Deficit Disorder With Hyperactivity |
| Norepinephrine | CONTRIBUTES TO | Attention Deficit Disorder With Hyperactivity |
| Serotonin | CONTRIBUTES TO | Attention Deficit Disorder With Hyperactivity |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00182#mechanism-of-action](https://go.drugbank.com/drugs/DB00182#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Amphetamine](https://en.wikipedia.org/wiki/Amphetamine)
  - [https://en.wikipedia.org/wiki/Adderall#Mechanism_of_action](https://en.wikipedia.org/wiki/Adderall#Mechanism_of_action)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095132/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095132/)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142296/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142296/)
  - [https://www.uniprot.org/uniprot/Q05940#function](https://www.uniprot.org/uniprot/Q05940#function)
  - [https://www.uniprot.org/uniprot/Q96RJ0#function](https://www.uniprot.org/uniprot/Q96RJ0#function)
  - [https://en.wikipedia.org/wiki/Neurotransmitter](https://en.wikipedia.org/wiki/Neurotransmitter)
  - [https://en.wikipedia.org/wiki/Reuptake](https://en.wikipedia.org/wiki/Reuptake)
  - [https://en.wikipedia.org/wiki/Attention_deficit_hyperactivity_disorder](https://en.wikipedia.org/wiki/Attention_deficit_hyperactivity_disorder)
